期刊
TOXICOLOGY AND APPLIED PHARMACOLOGY
卷 358, 期 -, 页码 35-42出版社
ACADEMIC PRESS INC ELSEVIER SCIENCE
DOI: 10.1016/j.taap.2018.09.007
关键词
Baicalein; Human Lung Fibroblast; Fibroblast-To-Myofibroblast Differentiation; alpha-SMA Filament; microRNA-21
资金
- National Natural Science Foundation of China [81573483]
- Jiangsu Overseas Research & Training Program for University Prominent Young & Middle-aged Teachers and Presidents
Fibroblast-to-myofibroblast differentiation is a highly important pathological characteristic of pulmonary fibrosis. In this study, we aimed to investigate the effects and mechanisms of baicalein on the differentiation of human lung fibroblasts. Baicalein reduced the levels of alpha-smooth muscle actin (alpha-SMA) mRNA and protein expression in TGF-beta 1-treated human lung fibroblasts. It also decreased the contents of collagen type I and fibronectin in time- and dose-dependent manners, and retardedTGF-beta 1-stimulated alpha-SMA filament formation. Baicalein diminished the expression of miR-21, and miR-21 mimics partially antagonized the effects of baicalein. Additionally, Baicalein inhibited the miR-21 transcriptor STAT3 activity but not AP-1 activity. Moreover, the expression of Spry 1 protein, a miR-21 known target, was improved by baicalein treatment, but the level of Smurf2 protein, another miR-21 target, was not interfered. Collectively, these results demonstrated that baicalein can attenuate TGF-beta 1-induced human lung fibroblast differentiation by inhibiting the miR-21 expression.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据